Rising Infectious Diseases and Investment in R&D to Foster the Growth of the Global Sjogren’s Syndrome Market

Published: Apr 2021

The global Sjogren’s syndrome market is anticipated to grow at a CAGR of 4.6% during the forecast period (2021-2027). The factors contributing to the growth of the market include rising Sjogren’s syndrome and other autoimmune diseases. For instance, according to the American College of Rheumatology, in a large US observational registry, out of a total of 24,528 patients, 7870 (31.2%) were found to be diagnosed with Sjogren’s syndrome. It was also observed that the syndrome was more likely to be seen in older and female persons and was associated with seropositivity. 

Browse the full report description Global Sjogren’s Syndrome Acids Market Size, Share & Trends Analysis Report by Test (blood test, Eye test, imaging test, and Biopsy), By Drug Type (Pilocarpine, Cyclosporine, Hydroxychloroquine, and Immunosuppressive Agents), Type (Primary Sjogren’s Syndrome, Secondary Sjogren’s Syndrome) and Forecast 2021-2027 at https://www.omrglobal.com/industry-reports/sjogrens-syndrome-acids-market

Further according to the National stem Cell Foundation, it is estimated by the American Autoimmune related diseases Association (AARDA) that almost 50 million Americans are living with autoimmune diseases bearing a cost of $86 billion per year. As per the US Department of Health and Human Services (HHS), these diseases are the fourth-largest cause of disability among wo9men in the US and the eighth largest cause of women’s mortality rates. 

Moreover, the collaboration between public associations raises awareness regarding the treatment and diagnosis for Sjogren’s syndrome that further projected to propel the market growth during the forecast period. For instance, in May 2018, The American Autoimmune Related Disease Association announce its collaborative partnership with Allegheny Health Network to improve and work towards the health conditions of patients with autoimmune diseases.  With this collaboration, both the associations will be on track to accelerate the diagnosis and treatment for curing autoimmune diseases and also fulfil the need and demand for increasing diagnostic and treatment centres. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Drug Type 

o By Type

  • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape- Novartis AG, Aldeyra Therapeutics, Inc., Bristol-Myers Squibb Company, Pfizer Inc., Amgen Inc. 

Key Questions Addressed by the Report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Sjogren’s Syndrome Market Report Segment

By Drug Type

  • Pilocarpine
  • Cyclosporine 
  • Hydroxychloroquine
  • Immunosuppressive Agents

By Type

  • Primary Sjögren’s Syndrome
  • Secondary Sjögren’s Syndrome

Global Sjogren’s syndrome Market Report Segment by Region

North America

  • United States
  •  Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  •  India
  • Rest of the Asia-Pacific

Rest of the World

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/sjogrens-syndrome-acids-market